Aprea Therapeutics, Inc. Common stock (APRE) is a publicly traded Healthcare sector company. As of November 4, 2026, APRE trades at $0.52 with a market cap of $6.18M and a P/E ratio of -0.75. APRE moved +0.00% today. Year to date, APRE is -41.15%; over the trailing twelve months it is -64.14%. Its 52-week range spans $0.41 to $2.69. Analyst consensus is strong buy with an average price target of $3.30. Rallies surfaces APRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for APRE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $6.18M |
| P/E Ratio | -0.75 |
| EPS | $-0.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.69 |
| 52-Week Low | $0.41 |
| Volume | 537 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.18K |
| Net Income | $-12.31M |
| Gross Margin | 0.00% |
4 analysts cover APRE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.30.